| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 09/16/2004 | CA2517844A1 Quinazolines useful as modulators of ion channels |
| 09/16/2004 | CA2512243A1 N-aryl heteroaromatic products, compositions containing same and use thereof |
| 09/15/2004 | EP1457490A1 5-membered N-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 09/15/2004 | EP1456203A1 Ethylene diamine derivatives and their use as orexin-receptor antagonists |
| 09/15/2004 | EP1456201A1 Benzhydryl derivatives |
| 09/15/2004 | EP1456200A1 Lactams as tachykinin antagonists |
| 09/15/2004 | EP1456182A1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i) |
| 09/15/2004 | EP1456181A1 Methods for preparing sodium-hydrogen exchanger type-1 inhibitors |
| 09/15/2004 | EP1456180A1 3,4-diarylpyrazoles and their use in the therapy of cancer |
| 09/15/2004 | EP1456178A1 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment of cns disorders |
| 09/15/2004 | EP1456172A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 09/15/2004 | EP1455579A1 Pyrazoles-pyrimidine fungicides |
| 09/15/2004 | EP1363902B1 Chemical compounds |
| 09/15/2004 | EP1212317B1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 09/15/2004 | EP0990653B1 2-oxoimidazole derivatives |
| 09/15/2004 | EP0889726B1 Novel cycloalkyl substituted imidazoles |
| 09/15/2004 | EP0693072B9 Method for the synthesis of 4- and/or 5-(di)substituted 2-aminoimidazoles from 2-aminoimidazoles and aldehydes |
| 09/15/2004 | CN1529704A 3-(4-amidopyrrol-2-2ylmethlidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/15/2004 | CN1529703A 新的吲哚衍生物 The new indole derivatives |
| 09/15/2004 | CN1529595A 4,5-hydro-1H-pyrazole derivative having protent CB1-antagonistic |
| 09/15/2004 | CN1528750A Pyrimidine derivatives and preparing method thereof |
| 09/15/2004 | CN1528742A Compound for treating asthma, irritability an a inflammation and its intermediate |
| 09/15/2004 | CN1166645C Bicyclic heterocyles, medicaments contg. these compounds, their use and methods for prodn. thereof |
| 09/15/2004 | CN1166643C 4-phenyl-pyrimidine derivatives |
| 09/15/2004 | CN1166638C Novel benzo-[3,4] cyclobutano [1,2-C] pyrroles compound, its prepn. and medicine composition containing the same |
| 09/15/2004 | CN1166636C Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression |
| 09/15/2004 | CN1166633C New alpha-amino acid sulfuryl compounds, its preparing method and medicinal composition containing them |
| 09/15/2004 | CN1166363C Use of moxonidine for postmyocardial infarction treatment |
| 09/14/2004 | US6790957 Converting tertiary hydroxy group of a triazole antifungal compound into a phosphate group to improve aqueous solubility |
| 09/14/2004 | US6790860 Pyrrolidine derivatives |
| 09/14/2004 | US6790852 Heterocyclic nitrogen compounds such as 2-(2,6-dichlorophenyl) -4-(3-bromophenyl)-5-(2-(3- hydroxypropylamino)pyrimidin-4-yl) -n-h-imidazole, used as tyrosine kinase inhibitors; anticarcinogenic or antitumor agents |
| 09/14/2004 | US6790845 Having an attached non-aromatic heterocyclic ring |
| 09/14/2004 | US6790810 Tetrazolinone derivatives |
| 09/10/2004 | WO2004076457A1 Solvent-free process for the preparation of pyrrolo (3,4c) pyrrole compounds |
| 09/10/2004 | WO2004076456A1 Solvent-free process for the preparation of diketopyrrolopyrrole derivatives |
| 09/10/2004 | WO2004076442A1 Polymorphs of losartan |
| 09/10/2004 | WO2004076429A1 Ethynyl derivatives serving as factor xa inhibitors |
| 09/10/2004 | WO2004076424A1 Heterocyclic kinase inhibitors |
| 09/10/2004 | WO2004076412A2 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | WO2004076410A2 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/10/2004 | WO2004076407A2 Pyrrolidine derivatives as oxytocin antagonists |
| 09/10/2004 | WO2004076406A2 Losartan potassium polymorphs and process for the preparation thereof |
| 09/10/2004 | WO2004075895A1 Ocular hypotensive agent |
| 09/10/2004 | WO2004075840A2 Selective non-steroidal glucocorticoid receptor modulators |
| 09/10/2004 | WO2004075823A2 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/10/2004 | WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators |
| 09/10/2004 | WO2004050643A3 Non-nucleoside reverse transcriptase inhibitors |
| 09/10/2004 | WO2004047769A3 Benzimidazoles and analogs thereof as antibacterials |
| 09/10/2004 | WO2004022523A3 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 09/10/2004 | WO2003087092A3 Inhibitors of serine proteases, particularly hepatitis c virus ns3 - ns4 protease |
| 09/10/2004 | WO2003061652A8 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 09/10/2004 | CA2517391A1 Ethynyl derivatives serving as factor xa inhibitors |
| 09/10/2004 | CA2517256A1 Aminoheteroaryl compounds as protein kinase inhibitors |
| 09/10/2004 | CA2516900A1 Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/10/2004 | CA2516684A1 Selective non-steroidal glucocorticoid receptor modulators |
| 09/10/2004 | CA2516660A1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament |
| 09/09/2004 | US20040176603 Substituted nitrogen-containing heterobicycles, the preparation thereof and their use as pharmaceutical compositions |
| 09/09/2004 | US20040176594 Drugs that inhibit phosphorylation kinases as an antigrowth or antiproliferation agent |
| 09/09/2004 | US20040176443 Capsaicin receptor ligands |
| 09/09/2004 | US20040176433 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 09/09/2004 | US20040176428 treatment of Type 2 diabetes mellitus, obesity and lipid disorders; coadministration with HMG CoA reductase inhibitors |
| 09/09/2004 | US20040176400 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 09/09/2004 | US20040176399 A2B adenosine receptor antagonists |
| 09/09/2004 | US20040176396 anti-protoazoal; poultry feed; therapy for cytokine mediated disease i.e. osteoarthritis, cerebral malaria, chronic pulmonary inflammatory disease, silicosis, pulmonary sarcosis, bone resorption diseases, reperfusion injury, graft v. host rejection |
| 09/09/2004 | US20040176389 Piperazine oxime dervatives having nk-1 receptor antagonistic activity |
| 09/09/2004 | US20040176388 example compound: cis-1-[(2-chloro-3-trifluoromethylphenyl)acetyl]-6-(3,4,5-trimethylpiperazin-1-yl)indole; treatment of CNS and other disorders |
| 09/09/2004 | US20040176385 treating cancer by inhibiting phosphotidylinositol 3-kinase; in combination with other known agents to modulate cellular proliferation |
| 09/09/2004 | US20040176382 treatment of inflammation, proliferative diseases, and certain cardiovascular disorders as well as Alzheimer's disease; |
| 09/09/2004 | US20040176379 agonist effect from one or more of a somatostatin subtype receptor; diabetes mellitus, hyperlipidemia, insulin insensitivity, Syndrome X; inhibiting the proliferation of helicobacter pylori |
| 09/09/2004 | US20040176377 inhibitors of glycogen synthase kinase-3 beta; treatment of diabetes or neurodegenerative diseases such as Alzheimer's disease; 6-(2-butylamino-pyrimidin-4-yl)-3-oxo-2,3-dihydro-pyridazine-4-carboxylic acid (3-pyridin-3-yl-propyl)-amide, as example |
| 09/09/2004 | US20040176363 N-Acylpiperazine derivatives; cardiovascular disorders; anticoagulants |
| 09/09/2004 | US20040176358 Compositions and methods relating to novel compounds and targets thereof |
| 09/09/2004 | US20040176348 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 09/09/2004 | US20040176325 P38 MAP kinase inhibitors comprising indazole derivatives; antiinflammatory and antiproliferative agents; autoimmune, bone, and neurodegenerative disorders; viricides, infections |
| 09/09/2004 | US20040176271 2-amino-4-aryl or heteroaryl pyridines or pyrimidines; Janus kinases (JAK) |
| 09/09/2004 | DE10308907A1 Ethynylderivate Ethynylderivate |
| 09/09/2004 | DE10306250A1 Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Arylheterozyklen, processes for their preparation and their use as medicaments |
| 09/08/2004 | EP1454902A1 N- (substituted five-membered di-or triaza diunsaturated ring)carbonyl guanidine derivateives for the treatment of ischemia |
| 09/08/2004 | EP1454901A1 Piperazine compounds and pharmaceutical compositions containing them. |
| 09/08/2004 | EP1454898A1 Novel phenylalanine derivative |
| 09/08/2004 | EP1453826A1 Amorphous form of 2-n-butyl-3-[[2-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro[4,4'] non-1-en-4-one |
| 09/08/2004 | EP1453823A1 2-guanidino-4-heterocyclylquinazolines |
| 09/08/2004 | EP1453811A2 Peroxisome proliferator activated receptor agonists |
| 09/08/2004 | EP1453800A2 Protein kinase inhibitors |
| 09/08/2004 | EP1453789A2 N,n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/08/2004 | EP1453516A2 Novel tri-substituted pyrimidines, method for production and use thereof as medicament |
| 09/08/2004 | EP1453515A2 Method to treat cystic fibrosis |
| 09/08/2004 | EP1453503A2 Ep4 receptor agonist, compositions and methods thereof |
| 09/08/2004 | EP1453502A2 Pharmaceutical formulations comprising indolinone derivatives |
| 09/08/2004 | EP1345603A4 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents |
| 09/08/2004 | EP1289972B1 Serine protease inhibitors |
| 09/08/2004 | EP1201664B1 Benzimidazole compounds and drugs containing the same |
| 09/08/2004 | EP1089994B1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 09/08/2004 | EP0993456B1 2-substituted 4,5-diaryl imidazoles |
| 09/08/2004 | EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors |
| 09/08/2004 | CN1527829A Pyrazole derivatives as HIV reverse transcriptase inhibitors |
| 09/08/2004 | CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
| 09/08/2004 | CN1527701A Tablets quickly disintegrated in oral cavity |
| 09/08/2004 | CN1165546C New derivative of erythromycin, its preparation method and medicinal application |